Inhibitory effect of 2-substituted benzimidazoles on lymphocyte mitogenesis is associated with AhR-dependent mechanisms
Lab research · 2009
- What was studied
- Healthy-donor T cells stimulated with anti-CD3; benzimidazoles and TCDD interaction experiment
- Main finding
- At the reported Bemitil concentration, the table gives only 3±3% inhibition of mitogenesis. The combination with TCDD differed from the Bliss-model expectation. This supports an experimental interaction question, not a claim that Bemitil strongly suppresses human immunity.
Study data at a glance
- Participants or experimental model
- Healthy-donor T cells stimulated with anti-CD3; benzimidazoles and TCDD interaction experiment
- Reported results
- At the reported Bemitil concentration, the table gives only 3±3% inhibition of mitogenesis. The combination with TCDD differed from the Bliss-model expectation. This supports an experimental interaction question, not a claim that Bemitil strongly suppresses human immunity.
Study limitations and source details
Study limitations
- Conference abstract and indexed table excerpt, not a full clinical study.
- AhR involvement is a proposed mechanism; direct receptor binding and clinical immunosuppression were not demonstrated.
- No MS patients, demyelination outcome or clinical benefit assessment.
Source details
Russian conference abstract; indexed PDF excerpt
The summary reflects the results reported in the cited source.
Indexed abstract and table text reviewed
Sources checked
Citation
E. S. Sibiryak, S. V. Sadovnikov, S. V. Sibiryak. Inhibitory effect of 2-substituted benzimidazoles on lymphocyte mitogenesis is associated with AhR-dependent mechanisms Medical Immunology. 2009;11(4–5):335. Conference abstract